Abbott Laboratories Receives Approval from Health Canada for Whole Blood Rapid Test
Abbott Laboratories has received approval from Health Canada for its whole blood rapid test to assess concussions. The test, which provides lab-quality results in 15 minutes, enables clinicians to evaluate patients with suspected mild traumatic brain injuries at the bedside.
Key Features of the Test
- Provides lab-quality results in 15 minutes
- Enables bedside evaluation of patients with suspected mild traumatic brain injuries
- Reduces the need for sending samples to a lab
Impact on Patient Care and Efficiency
The approval of this test is expected to improve patient care and efficiency in emergency rooms. It may also expand testing to various healthcare settings beyond hospital emergency departments.
Company Commitment to Timely and Effective Healthcare Solutions
This development is a testament to Abbott Laboratories’ commitment in providing timely and effective healthcare solutions. The company’s efforts to bring this technology closer to patients demonstrate its dedication to improving healthcare outcomes.